Brand profile · Pharmaceutical Manufacturing

Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics)

Prestige Biopharma Group is a Pharmaceutical Manufacturing brand in Singapore. Publicly held, at prestigebio.com. Five addresses sit on record, spread over four office countries. It employs 92 people, on the record. It lists vaccines, diagnostics and research and development among its specialties. Its latest round on record is Series unknown, with no amount recorded. It is listed alongside four similar brands, mostly in Biotechnology Research.

Profile live Public Company Founded 2015 4 office countries 1 funding round

Key facts

Counted staff
92
self-reported band not used
Founded
2015
11 years
Legal entities
None matched
Office countries
4
5 addresses
Funding rounds
1
Series unknown · Feb 2009
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Description

Prestige Biopharma (PBP) is an innovative biopharmaceutical company specializing in the discovery and development of innovative biologics and biosimilars. PBP1510 (Ulenistamab) is the First-in-Class Pancreatic Cancer drug which is on the stage of 1/2a global clinical phase. Based on our innovative biomarker, PAUF, we are continuing the challenge for overcoming hard-to-treat diseases such as pancreatic cancer.

We are developing biosimilars to contribute on the patient's drug accessibility. Over 18 biosimilars we have been developing since 2015.

And also, we are expanding the application of PAUF biomarker to the diagnostics. To expand the effectiveness of pancreatic cancer treatment, we are developing the diagnostic device.

The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis. In parallel with our efforts to enhance safety, efficacy, and affordability of existing antibody therapeutics, PBP thrives to search for new targets and candidates with a goal to free mankind from devastating diseases

Established on core values cherishing life and fostering the spirit of philanthropy, Prestige BioPharma promises to grow everyday to make our dream come true.

Specialties

All 13 specialties
  • Pharmaceuticals
  • Manufacturing
  • Clinical Trials
  • Research and Development
  • Antibody Therapeutics
  • Biosimilars
  • Vaccines
  • CDMO
  • Pancreaticcancerdrug
  • noveldrugs
  • diagnostics
  • pancreaticeCancer
  • PAUF

Locations

4
Countries with an office address5 addresses on record
SingaporeprimaryAustraliaBelgiumSouth Korea

Country footprint

Offices in 4 countriesCountry footprint: 4 countries, primary SG. Codes: SG, AU, BE, KR.4 countriesprimary SGSGAUBEKR
Show as table · Offices in 4 countries
Offices in 4 countries
Countries4
Primary countrySG

All codes: SG AU BE KR

Addresses

  • BEBelseledorp 116; Belsele, Flemish Region 9111
  • AU58 Gipps St; Collingwood, Victoria 3066
  • SG21 Biopolis Road; #04-24/28 Nucleos South Building,; Singapore, 138567Primary
  • SG20 Biopolis Way, #05-01 Biopreneur 5; Centros Building; Biopolis, Singapore 138668
  • KR197, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si; Chungcheongbuk-do, Osong 28161

Grid intelligence Members

Funding

Last round · 1 February 2009Amount not recordedSeries unknown
Rounds1
Round typeSeries unknown · venture round
Amount (USD)not recorded
Stage ranknot recorded
Investors named0
Since last round16 yr 11 mo

Funding

1 funding roundFunding timeline. Latest round 1 Feb 2009: Series unknown, amount not disclosed.20092026Series unknownamount not disclosed1 round
Show as table · 1 funding round
1 funding round
Rounds1
Axis2009 to 2026
Series unknown · 1 Feb 2009not disclosed

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

The people relation is never requested, so there is nothing here to unlock.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at this brand?

92 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.

Where does this brand have offices?

Five addresses on record across 4 countries. Primary: 21 Biopolis Road, #04-24/28 Nucleos South Building, Singapore 138567.

Has Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) raised funding?

One round. Latest 1 February 2009: Series unknown, no amount recorded.

What does this brand list as its specialties?

13 tags on the brand's own list, among them vaccines, diagnostics and research and development.

Which companies are listed alongside this brand?

16 profiles list Prestige Biopharma Group (Prestige Biopharma / Prestige Biologics) as a peer — 92nd percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Hummingbird Bioscience and Tessa Therapeutics Ltd list it back.

What is this brand's website?